Huang JF - Search Results

1

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.

Miao RY, Zhao HT, Yang HY, Mao YL, Lu X, Zhao Y, Liu CN, Zhong SX, Sang XT, Huang JF. Miao RY, et al. Among authors: huang jf. World J Gastroenterol. 2010 Jun 21;16(23):2931-42. doi: 10.3748/wjg.v16.i23.2931. World J Gastroenterol. 2010. PMID: 20556841 Free PMC article.

2

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.

Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, Zhao H, Chen W, Xu Y, Chi T, Yang Z, Cai J, Li H, Chen J, Zhong S, Mohanti SR, Lopez-Soler R, Millis JM, Huang J, Zhang H. Mao Y, et al. Gut. 2010 Dec;59(12):1687-93. doi: 10.1136/gut.2010.214916. Epub 2010 Sep 28. Gut. 2010. PMID: 20876776

3

Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.

Sun Y, Yang H, Mao Y, Xu H, Zhang J, Li G, Lu X, Sang X, Zhao H, Zhong S, Huang J, Zhang H. Sun Y, et al. J Gastroenterol Hepatol. 2011 Jul;26(7):1207-12. doi: 10.1111/j.1440-1746.2011.06733.x. J Gastroenterol Hepatol. 2011. PMID: 21443671

4

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China.

Liu L, Miao R, Yang H, Lu X, Zhao Y, Mao Y, Zhong S, Huang J, Sang X, Zhao H. Liu L, et al. Am J Surg. 2012 Jun;203(6):741-50. doi: 10.1016/j.amjsurg.2011.05.010. Epub 2011 Dec 15. Am J Surg. 2012. PMID: 22177551

5

Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.

Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y. Wang Y, et al. J Gastroenterol Hepatol. 2014 Mar;29(3):597-602. doi: 10.1111/jgh.12461. J Gastroenterol Hepatol. 2014. PMID: 24236824

6

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.

Miao R, Luo H, Zhou H, Li G, Bu D, Yang X, Zhao X, Zhang H, Liu S, Zhong Y, Zou Z, Zhao Y, Yu K, He L, Sang X, Zhong S, Huang J, Wu Y, Miksad RA, Robson SC, Jiang C, Zhao Y, Zhao H. Miao R, et al. J Hepatol. 2014 Oct;61(4):840-9. doi: 10.1016/j.jhep.2014.05.025. Epub 2014 May 22. J Hepatol. 2014. PMID: 24859455

7

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy.

Lu X, Zhao H, Yang H, Mao Y, Sang X, Miao R, Xu Y, Du S, Xu H, Chi T, Yang Z, Zhong S, Huang J. Lu X, et al. J Surg Oncol. 2009 Nov 1;100(6):488-93. doi: 10.1002/jso.21354. J Surg Oncol. 2009. PMID: 19653238

8

[Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].

Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB. Mao YL, et al. Among authors: huang jf. Zhonghua Yi Xue Za Zhi. 2008 Apr 8;88(14):948-51. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18756964 Chinese.

9

[Early recurrence after the resection of hepatocellular carcinoma].

Lu X, Zhao HT, Mao YL, Sang XT, Xu YY, Du SD, Xu HF, Chi TY, Yang ZY, Zhong SX, Huang JF. Lu X, et al. Among authors: huang jf. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):415-20. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008. PMID: 18795612 Chinese.

10

[A survival analysis of patients with early-stage hepatocellular carcinoma fulfilling Milan criteria and undergoing hepatectomy].

Liu LG, Miao RY, Lu X, Xu YY, Du SD, Xu HF, Chi TY, Yang HY, Yang ZY, Mao YL, Sang XT, Zhong SX, Huang JF, Zhao HT. Liu LG, et al. Among authors: huang jf. Zhonghua Yi Xue Za Zhi. 2010 Dec 14;90(46):3251-4. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21223780 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters